Aromatase inhibitors work after tamoxifen regimen ends
(Newser) -
New research shows that women can cut the risk of breast cancer recurring years later by taking certain drugs, the
Washington Post reports. Studies show that the drugs, known as aromatase inhibitors, sharply reduced the risk of cancer's return after women had finished their regimen of the widely used tamoxifen....
More »
